Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

The development of breeding tubercles in male zebrafish relies on a specific enzyme that processes hormones.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

New compounds show promise as nonsteroidal treatments for hair loss.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Camellia oleifera seed shell polyphenols and 1,3,6-tri-O-galloylglucose can help treat hair loss by reducing certain hormones and promoting hair growth.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

The compounds tested could potentially treat hair loss and alopecia.

Undariopsis peterseniana extract helps hair grow by activating certain cell growth pathways and could be a new treatment for hair loss.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

High TNF-α levels may increase hair loss risk after PRP therapy.

Rubus coreanum may help hair growth but not through the tested mechanisms, and none of the herbal extracts help with acne.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Use "female pattern hair loss" term, finasteride may help, more research needed.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.